MetaADEDB 2.0 @ LMMD
2-[4,7-Bis(carboxylatomethyl)-10-(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;gadolinium(3+)
(GFSTXYOTEVLASN-UHFFFAOYSA-K)
Structure
SMILES
[O-]C(=O)CN1CCN(CCN(CCN(CC1)CC(=O)[O-])CC(=O)O)CC(=O)[O-].[Gd+3]
Type(s)
Approved
ATC code(s)
V08CA02
Molecular Formula:
C16H25GdN4O8
Molecular Weight:
558.642
Log P:
-6.7061
Hydrogen Bond Acceptor:
12
Hydrogen Bond Donor:
1
TPSA:
170.65
CAS Number(s):
72573-82-1; 83678-67-5
Synonym(s)
1.
2-[4,7-Bis(carboxylatomethyl)-10-(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;gadolinium(3+)
2.
Gadoteric acid
3.
Gd-Dota
External Link(s)
PubChem Compound158536
92043526
71464587
ChEBI73732
CHEMBLCHEMBL3833326
DrugBankDB09132
KEGGdr:D08007
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1ErythemaFAERS: 2US FAERS
2Injection site erythemaFAERS: 2US FAERS
3Injection site extravasationFAERS: 2US FAERS
4Injection site painFAERS: 2US FAERS
5Throat irritationFAERS: 2US FAERS
6ApathyFAERS: 1US FAERS
7AsthmaFAERS: 1US FAERS
8Cardiovascular insufficiencyFAERS: 1US FAERS
9ConjunctivitisFAERS: 1US FAERS
10Contrast media allergyFAERS: 1US FAERS
11Contrast media reactionFAERS: 1US FAERS
12DysgeusiaFAERS: 1US FAERS
13EczemaFAERS: 1US FAERS
14HypersensitivityFAERS: 1US FAERS
15HypotensionFAERS: 1US FAERS
16Injected limb mobility decreasedFAERS: 1US FAERS
17Laryngeal discomfortFAERS: 1US FAERS
18Larynx irritationFAERS: 1US FAERS
19NauseaFAERS: 1US FAERS
20NeuritisFAERS: 1US FAERS
21Sense of oppressionFAERS: 1US FAERS
22SyncopeFAERS: 1US FAERS
23TachycardiaFAERS: 1US FAERS
24Unresponsive to stimuliFAERS: 1US FAERS
25UrticariaFAERS: 1US FAERS
26VertigoFAERS: 1US FAERS
27VomitingFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.